Eli Lilly Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Eli Lilly

LLY 1,076

+0.4%

Dec 24 12:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: D.J.Smyth who wrote (194)	5/1/1998 10:05:00 AM
From: Anthony Wong	Read Replies (1) of 642

Really, who cares about these analysts downgrades, when they can upgrade internet stocks at this point. May be they want to buy it back in the low 50's before the run-up when LLY presents the Evista data at the May conference. What a joke! Anyway, just for the record: Eli Lilly & Co. Cut to Near-Term 'Accumulate' at Merrill Bloomberg News May 1, 1998, 4:29 a.m. PT Princeton, New Jersey, May 1 (Bloomberg) -- Eli Lilly & Co. (LLY US) was downgraded to near-term ''accumulate'' from near-term ''buy'' by analyst Richard R. Vietor at Merrill Lynch & Co. The 12-month target price is $82.00 per share. The long-term rating was also cut to ''accumulate'' from ''buy.'' -- Andrew Bekoff in the Princeton, New Jersey newsroom, (609)279-3652

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next